Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Citi
AstraZeneca
US Department of Justice
Covington
Chinese Patent Office
Teva
Colorcon
Harvard Business School
Moodys
Healthtrust

Generated: August 22, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: clofarabine

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Abon Pharms Llc
CLOFARABINE
clofarabine
INJECTABLE;IV (INFUSION)204029ANDAFresenius-Kabi63323-572-701 VIAL, SINGLE-USE in 1 CARTON (63323-572-70) > 20 mL in 1 VIAL, SINGLE-USE
Genzyme
CLOLAR
clofarabine
INJECTABLE;IV (INFUSION)021673NDAsanofi-aventis U.S. LLC0024-5860-011 VIAL, SINGLE-USE in 1 BOX (0024-5860-01) > 20 mL in 1 VIAL, SINGLE-USE
Genzyme
CLOLAR
clofarabine
INJECTABLE;IV (INFUSION)021673NDAsanofi-aventis U.S. LLC0024-5917-011 VIAL, SINGLE-USE in 1 BOX (0024-5917-01) > 20 mL in 1 VIAL, SINGLE-USE
Genzyme
CLOLAR
clofarabine
INJECTABLE;IV (INFUSION)021673NDA AUTHORIZED GENERICsanofi-aventis U.S. LLC0955-1746-011 VIAL, SINGLE-USE in 1 BOX (0955-1746-01) > 20 mL in 1 VIAL, SINGLE-USE
Genzyme
CLOLAR
clofarabine
INJECTABLE;IV (INFUSION)021673NDAGenzyme Corporation58468-0100-11 VIAL, SINGLE-USE in 1 CARTON (58468-0100-1) > 20 mL in 1 VIAL, SINGLE-USE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Dow
US Army
Queensland Health
US Department of Justice
UBS
Moodys
Federal Trade Commission
QuintilesIMS
Mallinckrodt

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot